EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment

Chenhao Jiang, Jianhui Nie iD, Li Zhang iD

Viruses · 2026

DOI: 10.3390/v18101116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Chenhao Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control, Bei…. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesvirus 1, Human, Simplexvirus, Herpesvirus 2, Human. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus (HSV) is a highly prevalent neurotropic DNA virus that causes orolabial herpes, genital herpes, keratitis, neonatal infection, meningitis and encephalitis. HSV-1 and HSV-2 share epithelial entry, lytic replication, immune evasion, lifelong sensory-ganglion latency and periodic reactivation, yet they differ in typical transmission routes, anatomical recurrence and public-health burden. Rather than mechanically separating both viruses throughout, this review emphasizes shared HSV biology and highlights type-specific differences where they affect clinical interpretation or intervention design. We connect glycoprotein-mediated entry, receptor use, axonal transport, immune evasion and latency with mucocutaneous, ocular, neurologic, neonatal and genital disease. We then synthesize lessons from failed glycoprotein-D vaccine trials, multivalent and mRNA platforms, helicase–primase inhibitors, monoclonal antibodies, RNA-based approaches, genome editing and latency-directed strategies. A mechanism-guided HSV strategy should reduce acquisition, shedding and recurrence, prevent ocular, neurologic and neonatal complications, manage antiviral resistance and ultimately address latent infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes SimplexHerpesvirus 1, HumanSimplexvirusHerpesvirus 2, HumanHumansAntiviral AgentsVirus LatencyAnimalsImmune Evasion

Stichwörter der Autor:innen

HSV-1HSV-2antiviral therapygenital herpesherpes simplex virusimmune evasionkeratitislatencyvaccine

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China.
  • National Vaccine and Serum Institute (NVSI), Beijing 101111, China.

ORCID-Profile: Jianhui Nie, Li Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jiang, C., Nie, J., & Zhang, L. (2026). Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment. Viruses. https://doi.org/10.3390/v18101116

Vancouver

Jiang C, Nie J, Zhang L. Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment. Viruses. 2026. doi:10.3390/v18101116

BibTeX
@article{Jiang2026,
  author = {Jiang, Chenhao and Nie, Jianhui and Zhang, Li},
  title = {Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18101116}
}
Kostenlos starten →